TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/24 18:59 | 3/19/24 | IMRX | Immuneering Corp | DE | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 55 | 2.77 | 0 | 20 | 1 | 3,177 | D | ||||||||||||||
3/24/22 16:39 | 3/23/22 | IMRX | Immuneering Corp | DE | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 24 | 8.02 | 0 | 3 | 0 | 3,152 | D | ||||||||||||||
9/14/21 16:47 | 9/13/21 | IMRX | Immuneering Corp | DE | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P | 48 | 22.87 | 0 | 2 | 0 | 3,147 | D | ||||||||||||||
8/4/21 06:06 | 8/3/21 | IMRX | Immuneering Corp | DE | Health | Drug | Pharmaceutical Preparations | Zeskind Benjamin J. | MA | DOT | P,CEO | P.d | 31 | 15.00 | 0 | 2 | 0 | 3,145 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |